Edition:
India

Diplomat Delays Release Of 2018 Financial Results And Filing Of 10-K


Friday, 22 Feb 2019 

Feb 22 (Reuters) - Diplomat Pharmacy Inc ::DIPLOMAT DELAYS RELEASE OF 2018 FINANCIAL RESULTS AND FILING OF 10-K.DIPLOMAT PHARMACY INC - WILL PROVIDE UPDATED OUTLOOK WHEN IT REPORTS 2018 RESULTS..DIPLOMAT PHARMACY INC - COMPANY WITHDRAWS 2019 FULL YEAR PRELIMINARY OUTLOOK PROVIDED IN JANUARY.DIPLOMAT PHARMACY INC - COMPANY EXPECTS TO FILE ITS ANNUAL REPORT ON FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 2018 SOON AFTERWARDS..DIPLOMAT PHARMACY INC - WILL NEED TO RECORD A NON-CASH IMPAIRMENT CHARGE RELATED TO ITS PBM BUSINESS..DIPLOMAT PHARMACY INC - CHARGE IS EXPECTED TO BE EQUAL TO A SIGNIFICANT PORTION OF PBM'S GOODWILL AND DEFINITE-LIVED INTANGIBLE ASSETS.DIPLOMAT PHARMACY INC - JANUARY RESULTS HAVE COME IN SIGNIFICANTLY BELOW EXPECTATIONS.DIPLOMAT PHARMACY - PBM'S GOODWILL AND DEFINITE-LIVED INTANGIBLE ASSETS TOTALED ABOUT $630 MILLION AS OF DECEMBER 31, 2018, PRIOR TO IMPAIRMENT CHARGES.DIPLOMAT PHARMACY INC - NOTIFIED OF ADDITIONAL CUSTOMER LOSSES IN ITS PBM BUSINESS SINCE EARLY JANUARY.DIPLOMAT PHARMACY INC - CHARGE RELATES TO 2017 ACQUISITIONS OF NPS AND LDI AND IS DRIVEN BY REDUCED FINANCIAL FORECASTS FOR PBM BUSINESS..DIPLOMAT PHARMACY INC - FULL-YEAR 2018 REVENUES AND TOTAL ADJUSTED EBITDA ARE NOT IMPACTED BY ANY IMPAIRMENT CHARGE.DIPLOMAT PHARMACY INC - OBSERVING INCREASED COMPETITIVE PRESSURE IN SPECIALTY MARKET, DRIVING A REDUCED OUTLOOK FOR SCRIPT VOLUMES IN 2019. 

Company Quote

5.24
0.08 +1.55%
11:29pm IST